Enhancement of pre-existing DNA adducts in rodents exposed to cigarette smoke

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 424, Issue 1-2, 1999, Pages 195-205

  Gupta, Ramesh C ^a   Arif, Jamal M ^a   Gairola, C Gary ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

32P postlabeling; Cigarette smoke; DNA adduct; Guinea pig; I compound; Mouse; Rat

Indexed keywords

CIGARETTE SMOKE; PHOSPHORUS 32;

ANIMAL EXPERIMENT; ARTICLE; BLADDER; CONTROLLED STUDY; DNA ADDUCT; GUINEA PIG; HEART; ISOTOPE LABELING; LARYNX; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING; TRACHEA;

ANIMALS; CARCINOGENS; DNA ADDUCTS; DNA DAMAGE; GUINEA PIGS; MICE; ORGAN SPECIFICITY; RATS; SMOKING;

ANIMALIA; CAVIA; CAVIA PORCELLUS; NICOTIANA TABACUM; RODENTIA; SUS SCROFA;

EID: 0033535376     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00019-6     Document Type: Article

References (76)

1. L.B. Ries, B. Miller, B. Hankey, C. Kosary, A. Harras, B. Edwards, SEER Cancer Statistics Review, 1973-1992, NCI Bethesda, MD, NIH Publication No. 96-2789, 1995.
2. Shopland D.R., Eyre H.J., Pechacek T.F. Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? J. Natl. Cancer Inst. 83:1991;1142-1148.
3. Fielding J.E. Smoking: health effects and control (2). New Engl. J. Med. 313:1985;555-561.
4. International Agency for Research on Cancer, Tobacco Smoking, IARC Monographs, 38, 1986, 199-293.
5. Loeb L.A., Ernster V.L., Warner K.E., Abbots J., Laszlo J. Smoking and lung cancer: an overview. Cancer Res. 44:1984;5940-5958.
6. U.S. Surgeon General, The health consequences of smoking, Cancer (PHS) 82-50179 (1982), 5-8.
7. US EPA (EPA/600/6-90/006F), Respiratory health effects of passive smoking: Lung cancer and other disorders, Office of Health and Environmental Assessment, US EPA, Washington, DC, 1992.
8. Claxton L.D., Morin R.S., Hughes T.J., Lewtas J. A genotoxic assessment of environmental tobacco smoke using bacterial bioassays. Mutat. Res. 222:1989;81-99.
9. D. Hoffman, S.S. Hecht, in: C.S. Cooper, P.L. Grover (Eds.), Handbook of Experimental Pharmacology, Springer-Verlag, Berlin, 1990, pp. 63-102.
10. Bartsch H., Castegnaro M., Rojas M., Camus A.M., Alexandrove K., Lang M. Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer. Toxicol. Lett. 64/65:1992;477-483.
11. 32P-postlabeling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers Carcinogenesis. 12:1991;1301-1305.
12. Manchester D.K., Bownan E.D., Parhes N.B., Caporaso N.E., Weston A. Determination of polyaromatic hydrocarbon-DNA adducts in human placenta. Cancer Res. 52:1992;1499-1503.
13. 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA Carcinogenesis. 14:1993;151-154.
14. Mustonen R., Hemminki K. 7-Methylguanine levels in DNA of smokers' and nonsmokers' total white blood cells, granulocytes and lymphocytes. Carcinogenesis. 13:1992;1951-1955.
15. Phillips D.H., Hewer A., Martin C.N., Garner R.C., King M.M. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature. 336:1988;790-792.
16. 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin Cancer Res. 46:1986;5869-5877.
17. Santella R.M., Grinberg-Funes R.A., Young T.L., Dickey C., Singh V.N., Wang L.W., Perera F.P. Cigarette smoking-related polycyclic aromatic hydrocarbon-DNA adducts in peripheral mononuclear cells. Carcinogenesis. 13:1992;2041-2045.
18. Talaska G., Schamer M., Skipper P., Tannenbaum S., Caporaso N., Unruh L., Kadlubar F.F., Bartsch H., Malaveille C., Vineis P. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol. Biomarkers Prev. 1:1991;61-66.
19. Everson R.B., Randerath E., Santella R.M., Avitts T.A., Weinstein B., Randerath K. Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight. J. Natl. Cancer Inst. 80:1988;567-576.
20. Gallagher J.E., Mumford J., Li X., Shank T., Manchaster D., Lewtas J. DNA adduct profiles and levels in placenta, blood and lung in relation to cigarette smoking and smoky coal emissions. IARC Sci. Publ. 124:1993;283-292.
21. Izzoti A., D'Agostini F., Bagnasco M., Scatolini L., Rovida A., Balansky R.M., Cesarone C.F., De Flora S. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Cancer Res. 54:1994;1994s-1998s. Suppl.
22. Izzoti A., Rossi G.A., Bagnasco M., De Flora S. Benzo[a]pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers. Carcinogenesis. 12:1991;1281-1285.
23. 32P-postlabeling analysis Carcinogenesis. 11:1990;205-211.
24. 32P-postlabeling assay Carcinogenesis. 13:1992;1053-1074.
25. Nath R.G., Ocando J.E., Guttenplan J.B., Chung F.-L. 1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue. Cancer Res. 58:1998;581-584.
26. 32P-postlabeling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures Mutat. Res. 378:1997;65-75.
27. Zhao C., Geogellis A., Flato S., Palmberg L., Thunberg E., Hemminki K. DNA adducts in human nasal mucosa and white blood cells from smokers and nonsmokers. Carcinogenesis. 18:1997;2205-2208.
28. 32P-postlabeling analysis Carcinogenesis. 18:1997;339-344.
29. Wiencke J., Kelsey K., Varkonyi A., Semey K., Wain J., Mark E., Christiani D. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res. 55:1995;4910-4914.
30. Hemminki K. DNA adducts, mutations and cancer. Carcinogenesis. 14:1993;2007-2012.
31. Lutz W.K. In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat. Res. 65:1979;289-356.
32. Lutz W.K. Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogen. J. Cancer Res. Clin. Oncol. 112:1986;85-91.
33. Nesnow S., Ross J.A., Stoner G.D., Mass M.J. Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mouse. Toxicology. 105:1995;403-413.
34. Griffith R.B., Standafer S. Simultaneous mainstream-sidestream smoke exposure systems: II. The rat exposure system. Toxicology. 35:1985;13-24.
35. Gairola C.G. Free lung response of mice and rats to mainstream cigarette smoke exposure. Toxicol. Appl. Pharmacol. 84:1986;567-575.
36. Arif J.M., Gairola C.G., Glauert H.P., Kelloff G.J., Lubet R.A., Gupta R.C. Effects of dietary supplementation of N-acetylcysteine on cigarette smoke-related DNA adducts in rat tissues. Int. J. Oncol. 11:1997;1227-1233.
37. Gupta R.C., Sopori M.L., Gairola C.G. Formation of cigarette smoke-induced DNA adducts in the rat lung and nasal mucosa. Cancer Res. 49:1989;1916-1920.
38. Gairola C.G., Gupta R.C. Cigarette smoke-induced DNA adducts in the respiratory and nonrespiratory tissues of rats. Environ. Mol. Mutagen. 17:1991;253-257.
39. Gairola C.G., Wu H., Gupta R.C., Diana J.N. Mainstream and sidestream cigarette smoke-induced DNA adducts in C57BL and DBA mice. Environ. Health Perspect. 99:1993;253-255.
40. 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts Carcinogenesis. 3:1982;1081-1092.
41. 32P-postlabeling analysis of aromatic carcinogen-DNA adducts Cancer Res. 45:1985;5656-5662.
42. 32P-postlabeling test for structurally diverse DNA adducts Carcinogenesis. 7:1986;1543-1551.
43. 32P-Postlabeling for detection of DNA adducts, in: G.P. Pfeifer (Ed.), Technologies for Detection of DNA Damage and Mutations, Plenum, New York, 1996, pp. 45-61.
44. Sjoberg K. PTC in practice. Aldrichimica Acta. 13:1980;55-58.
45. 32P-postlabeling and thin layer chromatography, in: E.C. Friedberg, P.C. Hanawalt (Eds.), DNA Repair, Marcel Dekker, New York, 1988, pp. 399-417.
46. 32P-postlabeled DNA adducts J. Chromatogr. B: Biomed. Appl. 677:1996;265-273.
47. Arif J.M., Gairola C.G., Glauert H.P., Kelloff G.J., Lubet R.A., Gupta R.C. Inhibition of cigarette smoke-related lipophilic DNA adducts in rat tissues by dietary oltipraz. Carcinogenesis. 19:1998;1515-1517.
48. Diana J.N. Tobacco smoking and nutrition. Ann. New York Acad. Sci. 686:1993;1-11.
49. G. Pershagen, Passive smoking and lung cancer, in: J.M. Samet (Ed.), Epidemiology of Lung Cancer, Marcel Dekker, New York, 1994, pp. 109-130.
50. Witschi H., Espiritu I., Peake J.L., Wu K., Maronpot R.R., Pinkerton K.E. The carcinogenicity of environmental tobacco smoke. Carcinogenesis. 18:1997;575-586.
51. von Meyerinck L., Scherer G., Adlkofer F., Wenzel-Hartung R., Brune H., Thomas C. Exposure of rats and hamsters to sidestream smoke from cigarettes in a subchronic inhalation study. Exp. Pathol. 37:1989;186-189.
52. Coggins C.R., Ayres P.H., Mosberg A.T., sagartz J.W., Hayes A.W. Subchronic inhalation study in rats using aged and diluted sidestream smoke from a reference cigarette. Inhal. Toxicol. 5:1993;77-96.
53. Joad J.P., Bric J.M., Pinkerton K.E. Sidestream smoke effects on lung morphology and C-fibers in young guinea pigs. Toxicol. Appl. Pharmacol. 131:1995;289-296.
54. Penn A., Snyder C.A. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation. 88:1993;1820-1825.
55. Witschi H., Road J.P., Pinkerton K.E. The toxicology of environmental tobacco smoke. Annual Review of Pharmacology and Toxicology. 37:1997;29-52.
56. Manchester D.K., Weston A., Choi J.S., Trivers G.E., Fennessey P.V., Quintana E., Farmer P.B., Mann D.L., Harris C.C. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc. Natl. Acad. Sci. U.S.A. 85:1988;9243-9247.
57. Phillips D.H., Schoket B., Hewer A., Bailey E., Kostic S., Vincze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int. J. Cancer. 46:1990;569-575.
58. Flamini G., Romano G., Curigliano G., Chiominto A., Capelli G., Boninsegna A., Signorelli C., Ventura L., Santella R.M., Sgambatto A., Cittadini A. 4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study. Carcinogenesis. 19:1998;353-357.
59. Talaska G., Al-Juburi A.Z., Kadlubar F.F. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosine-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. U.S.A. 85:1991;9788-9791.
60. Degawa M., Stern S.J., Martin M.V., Guengerich F.P., Fu P.P., Ilett K.F., Kaderlik R.K., Kadlubar F.F. Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res. 54:1994;4915-4919.
61. 32P-postlabeling, and GC-MS detection of 4-Aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation Mutat. Res. 378:1997;97-112.
62. Godschalk R.W.L., Mass L.M., Van Zandwijk N., van't Veer L.J., Breedijk A., Borm P.J.A., Verhaert J., Kleinjans J.C.S., van Schooten F.J. Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers. Carcinogenesis. 19:1998;819-825.
63. Hsu T.-M., Zhang Y.-J., Santella R.M. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev. 6:1997;193-199.
64. 32Postlabeling-HPLC analysis of lipophilic DNA adducts from human lung Biomarkers. 2:1997;341-347.
65. 32P-adduct assay: recoveries of structurally diverse DNA adducts in the various enhancement procedures Carcinogenesis. 9:1988;1687-1693.
66. 32P-Postlabeling assay and basal values in rat tissues Carcinogenesis. 17:1996;917-924.
67. Arif J.M., Smith W.A., Gupta R.C. Tissue distribution of DNA adducts in rats treated by intramammillary injection with dibenzo[a,l]pyrene, 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene. Mutat. Res. 378:1997;31-39.
68. Arif J.M., Gupta R.C. Detection of DNA-reactive metabolites in serum and their tissue distribution in mice exposed to multiple doses of carcinogen mixtures: role in human biomonitoring. Carcinogenesis. 17:1996;2213-2219.
69. Church D.F., Pryor W.A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 64:1985;111-126.
70. Pryor W.A., Stone K. Oxidants in cigarette smoke. Ann. New York Acad. Sci. 686:1993;12-28.
71. Pryor W.A. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ. Health Perspect. 105:1997;875-882. Suppl.
72. Randerath K., Randerath E., Smith C.V., Chang J. Structural origins of bulky oxidative DNA adducts (type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence. Chem. Res. Toxicol. 9:1996;247-254.
73. Lloyd D.R., Phillips D.H., Carmichael P.L. Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem. Res. Toxicol. 10:1997;393-400.
74. Gairola C.G., Myers S.R., Pinorini-Godly M.T., Subramaniam S. Formation of smoke-induced hemoglobin adducts in rats. Fundam. Appl. Toxicol. 30:1996;96.
75. Melikian A.A., Sun P., Pierpont C., Coleman S., Hecht S.S. Gas chromatographic-mass spectrometric determination of benzo[a]pyrene and chrysene diol epoxide globin adducts in humans. Cancer Epidemiol. Biomarkers Prev. 6:1997;833-839.
76. Garg A., Beach A.C., Gupta R.C. Interception of reactive, DNA adduct-forming metabolites present in rodent serum following carcinogen exposure: implications for use of body fluids in biomonitoring. Teratogen. Carcinogen. Mutagen. 13:1993;151-166.